@phrmcypnkrck なるほど! 最近こんなとこで再注目されてたみたいですね😊 https://t.co/RVbe5aoL8c
> SARS-CoV-2のメインプロテアーゼ(Mpro)がこの種の治療薬の標的候補として特定されている。Mproは、ウイルス複製に関与する酵素である 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Research https://t.co/ja9WwNMz72
There is a lot to explore on these targets. https://t.co/NzCOTANXvU
RT @Crispercas20: https://t.co/ZqOP6Vsbhs 5-FU の派生化合物のcarmofurが新型コロナウイルスのMproをtargetにして効果があるそう、しっかり構造とってbinding pocketがわかるようになっている。
Here, we have determined the inhibitory effect of carmofur against SARS-CoV-2 infection on Vero E6 cells, as previously described in ref. https://t.co/L2ixhiXKNC via @naturemedicine
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
Un artículo en Nature Structural and Molecular Biology (https://t.co/7kBIzP8IBG) explica las bases estructurales por las cuales el fármaco antineoplásico (aquellos q impiden desarrollo de células tumorales malignas), carmofur, inhibe a la proteasa princip…
Research highlight: Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. "Carmofur inhibits viral replication in cells and is a promising lead compound to develop new antiviral treatment for COVID-19." https:…
最近は親分に媚びて、恩恵に被ろう、というやつばかりが中枢にいるんだろうね世の東西を問わず。 もともと一番最初に、ここに論文出したのが中国だろ。なんで「発生当事国と言われるのは陰謀」なの? と思って開いたらこんな話も https://t.co/OtmmtTo9JC
創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology | Nature Research: https://t.co/1xkBUxCO2Z
This paper of nature is understanding very well. but this is for a main protease, not papain-like protease. and using a discovered drug for cancer. How strength is it effect? https://t.co/ThBfuESBEQ
@felipeneto Olha os testes que são feitos são levados para laboratório e acho que o único problema que pode acontecer é algum erro na coleta. O teste mais exato é com a técnica molecular (PCR), tanto que a própria técnica é usada nas pesquisas.https://t.c…
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology | Nature Research: https://t.co/SuLa7HeTTv
創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology | Nature Research: https://t.co/9UThEX16WB
#biryeminettik Kanser ilacı carmofur da Covid virüsünü engelliyormuş. https://t.co/WtoC4Ue3tb
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった https://t.co/3Yc3MWW0xL カルモフールがSARS-CoV-2 Mproの触媒性システイン(Cys)残基 145を直接修飾することが明らかになった。
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @Crispercas20: https://t.co/ZqOP6Vsbhs 5-FU の派生化合物のcarmofurが新型コロナウイルスのMproをtargetにして効果があるそう、しっかり構造とってbinding pocketがわかるようになっている。
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
"The antineoplastic drug #carmofur is shown to inhibit the #SARSCoV2 main protease #Mpro" "Carmofur inhibits viral replication in cells (EC50= 24.30 μM) and is a promising lead compound to develop new antiviral #treatment for #COVID19" #XRayCrystalog…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @Crispercas20: https://t.co/ZqOP6Vsbhs 5-FU の派生化合物のcarmofurが新型コロナウイルスのMproをtargetにして効果があるそう、しっかり構造とってbinding pocketがわかるようになっている。
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
RT @EricTopol: An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin G…
Losing count of the treatment options tried for this weird disease so far! What would be the ultimate benchmark to claim a success?
An astute and succinct overview of the repurposing landscape to quickly get drugs vs #COVID19, by @universityofky's Kiplin Guy and colleagues https://t.co/vVVqFZryED @ScienceMagazine w/ @ScienceVisuals by @oooitsplasma https://t.co/JDVg7GTTCK https://t…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
RT @EricTopol: As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug…
As we dig out from the pandemic, the respect titer for structural biologists will soar. Here the potential of a #cancer drug to be repurposed against #SARSCoV2: crystal structure shows it binding its main polymerase (Mpro) https://t.co/cNtWrVAG6L @Natu…
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
COVID-19にアビガンを適用拡大するなら、カルモフールを適用拡大した方がエエんちゃうか? https://t.co/1H1ABSjJIM
"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur | Nature Structural & Molecular Biology" https://t.co/IpM0d1RUGi
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @NatureJapan: 創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
創薬:抗SARS-CoV-2薬の標的とその阻害剤の相互作用が結晶構造から明らかになった | Nature Structural & Molecular Biology https://t.co/hbdjuY26Ys #創薬 #SARS-CoV-2
RT @infdisease_news: Brief Communication: The X-ray crystal structure of Mpro in complex with #carmofur, a drug shown to inhibit #SARS-CoV-…
Drug discovery: Crystal structure reveals interactions between the drug target of SARS-CoV-2 and its inhibitor | Nature Structural & Molecular Biology https://t.co/wpeUAnGcsq #Drugdiscovery #SARS-CoV-2
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur https://t.co/l3NZKgtPsu
RT @infdisease_news: Brief Communication: The X-ray crystal structure of Mpro in complex with #carmofur, a drug shown to inhibit #SARS-CoV-…
Brief Communication: The X-ray crystal structure of Mpro in complex with #carmofur, a drug shown to inhibit #SARS-CoV-2, revealed that the carbonyl reactive group of carmofur is covalently bound to catalytic Cys145. https://t.co/C0clhwuzzi https://t.co/…
RT @tothur: Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur | Nature Structural & Molecular…
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur | Nature Structural & Molecular Biology https://t.co/EmKvngRAPN